289903-29-3

Basic information

• Product Name: benzyl N-(4-hydroxy-3-methoxybenzyl)carbamate
• Synonyms: benzyl N-(4-hydroxy-3-methoxybenzyl)carbamate
• CAS NO: 289903-29-3
• Molecular Weight: 287.315
• Mol File: 289903-29-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: benzyl N-(4-hydroxy-3-methoxybenzyl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl N-(4-hydroxy-3-methoxybenzyl)carbamate(289903-29-3)
• EPA Substance Registry System: benzyl N-(4-hydroxy-3-methoxybenzyl)carbamate(289903-29-3)

Safety Data

• Hazardous Substances Data: 289903-29-3(Hazardous Substances Data)

Upstream product

• 7149-10-2 vanillylamine hydrochloride 
• 501-53-1 benzyl chloroformate 
• 161196-85-6 3-methoxy-4-(methoxymethyloxy)benzonitrile 
• 4421-08-3 3-methoxy-4-hydroxybenzonitrile 
• 289903-27-1 (3-Methoxy-4-methoxymethoxy benzyl)carbamic Acid Benzyl Ester 
• 210918-31-3 3-methoxy-4-methoxymethoxybenzylamine 

Downstream Products

• 289903-33-9 2-{[4-(benzyloxycarbonylamino)methyl-2-methoxy]phenoxy}acetic acid 
• 119056-15-4 2-(2-methoxy-4-aminomethylphenoxy)-acetic acid 
• 289903-36-2 4-{4-[(benzyloxycarbonylamino)methyl]-2-methoxyphenoxy}-4-oxobutanoic acid benzyl ester 
• 289903-31-7 [4-(Benzyloxycarbonylamino-methyl)-2-methoxy-phenoxy]-acetic Acid Methyl Ester 

Relevant articles and documents

GLYCOSIDE COMPOUND

Compounds of formula (I″) wherein: R11, R12, R13, R14 and R15 are hydrogen, hydroxyl, C1-6 alkyl, C1-6 alkoxy, C1-6 alkyl-carbonyloxy, or a G-O— group, and at least one of R11, R12, R13, R14 and R15 is a G-O— group, wherein G is a saccharide residue,X1 is a single bond, or a methylene group, an ethylene group, a trimethylene group, a vinylene group or —CH═CH—CH2—,X2 is —CO—O— or —O—CO—,p and q are integer ofs 0 to 7, and p+q=0 to 8,Y1 is methylene, ethylene or an alkenylene group having a carbon number of 2 to 15 and 1 to 3 double bonds, andR16 and R17 are hydrogen, methyl or ethyl, or R16 and R17 form a C3-6 cycloalkyl group, are useful as GLP-1 secretion promoting agents.

Vanilloid analogues containing resinferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof

The present invention is related to new vanilloid analogues containing resiniferatoxin pharmacophores, pharmaceutical compositions comprising such analogues, and their uses as vanilloid receptor agonists and potent analgesics. The present invention provides a pharmaceutical composition for treating acute, chronic, inflammatory or neuropathic pains or for treating bladder hypersensitivity.